An investigator supported the World Anti-Doping Agency's actions in a doping case concerning 23 Chinese swimmers. The investigation revealed doubts expressed by WADA's science director regarding China's explanation of how the athletes were exposed to contamination.
WADA released an interim report from the Swiss prosecutor, Eric Cottier, who found no evidence of favoritism towards China in the case. Cottier deemed WADA's decision to trust Chinese authorities, who claimed the swimmers ingested a banned heart medication, as reasonable.
Despite initial skepticism, WADA's chief scientist could not exclude the contamination scenario. However, a review of the facts did not provide evidence to challenge the contamination explanation given by Chinese authorities.
Eleven swimmers who tested positive were allowed to continue competing at the upcoming Paris Olympics, as WADA chose not to pursue the case in 2021.
WADA President confirmed that there was no impropriety in the handling of the case and expressed intentions to take legal action against those making false allegations that damaged WADA's reputation.
The investigation was initiated following revelations by German broadcaster ARD and New York Times. Critics questioned the reliability of the investigation, citing its narrow focus and the investigator being handpicked by WADA.
While the report addressed some concerns, critics, including the U.S. Anti-Doping Agency CEO, raised questions about why WADA did not conduct its own investigation into the case.
The full report, due later this year, will include recommendations on WADA procedures and the world anti-doping code.
For more information on the Summer Olympics, visit AP Summer Olympics.
